Cargando…
Gene Therapy with Endogenous Inhibitors of Angiogenesis for Neovascular Age-Related Macular Degeneration: Beyond Anti-VEGF Therapy
Age-related macular degeneration (AMD) is the leading cause of substantial and irreversible vision loss amongst elderly populations in industrialized countries. The advanced neovascular (or “wet”) form of the disease is responsible for severe and aggressive loss of central vision. Current treatments...
Autores principales: | Prea, Selwyn M., Chan, Elsa C., Dusting, Gregory J., Vingrys, Algis J., Bui, Bang V., Liu, Guei-Sheung |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi Publishing Corporation
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4363820/ https://www.ncbi.nlm.nih.gov/pubmed/25821585 http://dx.doi.org/10.1155/2015/201726 |
Ejemplares similares
-
Performance of a Smart Device over 12-Months for Home Monitoring of Patients with Intermediate Age-Related Macular Degeneration
por: Prea, Selwyn, et al.
Publicado: (2023) -
Test Reliability and Compliance to a Twelve-Month Visual Field Telemedicine Study in Glaucoma Patients
por: Prea, Selwyn Marc, et al.
Publicado: (2022) -
Scaling the size of perimetric stimuli reduces variability and returns constant thresholds across the visual field
por: Bedggood, Phillip, et al.
Publicado: (2021) -
Melatonin Inhibits VEGF-Induced Endothelial Progenitor Cell Angiogenesis in Neovascular Age-Related Macular Degeneration
por: Lin, Liang-Wei, et al.
Publicado: (2023) -
Resistance to anti-VEGF therapy in neovascular age-related macular degeneration: a comprehensive review
por: Yang, Shiqi, et al.
Publicado: (2016)